Otolaryngology: Open Access

Abstracto

A Retrospective Cohort Analysis of Indications, Treatments, and Factors related to Otolaryngology visits for COVID-19 Patients

Zehbanaz Panwala

The Coronavirus SARS-CoV-2(COVID- 19) epidemic devastated communities and healthcare systems around the globe, with over 449 million accretive verified cases worldwide and a death risk overhead of5.9 million (1). Healthcare professionals modified routines and procedures to cover themselves, with a cross-sectional multiinstitutional check of 55 otolaryngology departments across North America revealing near-universal (n = 53 of 55,96.3) cancellations of optional cases at the height of the epidemic (2). With these oscillations in cases and responses, otolaryngology attending and resides have continued to operate and take call across the country, with ineluctable exposure to cases verified or under disquisition for COVID- 19(,3). Although otolaryngology symptoms of COVID-19 similar as olfactory dysfunction, sneezing, and nasal traffic have been well- characterized to date (4), there remains a deficit of literature establishing outpatient trends of otolaryngology consults since the onset of the epidemic, with the many published studies demonstrating variable changes in consult patterns Only one case series and one small cohort study have addressed the issue of or pharyngeal bleeding taking operation by otolaryngology services (,8).